Minnesotans with autism and obstructive sleep apnea will be able to use medical marijuana as of next July to manage their medical conditions.
Tag Archives: Anxiety
SPOKANE, Wash., Nov. 30, 2017 /Weed Wire/ — Many patients who are being treated for opioid addiction in a medication-assisted treatment clinic use marijuana to help manage their pain and mood symptoms. But new research led by Marian Wilson, Ph.D., of the Washington State University College of Nursing found that frequent marijuana use seems to strengthen the relationship between pain and depression and anxiety, not ease it.
From WEEDIQUETTE’s “Chronic Trauma” episode: Krishna accompanies rapper JohnboyCOOL to learn about medicinally treating his trauma with cannabis.
Research into the potential medical uses of marijuana compounds continues apace. Among the most recent, a study delved into why marijuana is an effective stress reducer.
On July 25, 2017, the New Jersey Medicinal Marijuana Program Review Panel revealed an initial recommendation to add migraines, Tourette’s Syndrome, chronic pain and anxiety to the list of qualifying conditions for those seeking medical marijuana treatment in the Garden State.
Today, the New Jersey Medicinal Marijuana Program Review Panel made initial recommendations to the Health Commissioner to approve chronic pain, migraine, anxiety and Tourette’s Syndrome as qualifying conditions for the medical marijuana program.
One of the most commonly touted benefits of marijuana is that it can help people sleep, but a new study conducted by Boston University seems to challenge that assumption.
A recently released Israeli study showed patients who used medical cannabis experienced less pain and more ability to function, according to a May 26, 2016, article at JPost.com. Medical marijuana has been legal in Israel for a decade and more than 20,000 are licensed to use it, JPost.com reported. However, “there has been no information about the users themselves,” said the study’s leader, Prof. Pesach Shvartzman of Ben-Gurion University.
In the past cannabis has been the scapegoat of mental health professionals. Much research indicates that use of the plant is responsible for a myriad of mental health problems. However, new research seems to point in a different direction. “Our findings suggest caution in the implementation of policies related to legalization of cannabis for recreational…
BELLEVUE, Wash., Feb. 18, 2016 /Weed Wire/ — Today at CannaCon 2016, Bellevue, WA based CannaSafety LLC announced increased production and broad availability of their flagship product CannaRelief™, the “world’s first cannabis antidote™” and first in a family of products.
Many venture capitalists are still nervous about investing in marijuana, despite a legal market estimated at $1.44 billion. Worries range from DEA enforcement action to scalability to a general squeamishness about “sin products.” A realistic way to take the risk/reward problem apart may be to look at the industry as a collection of mini-markets, each with unique characteristics.